Plasma aldosterone is independently associated with the metabolic syndrome
Abstract
The aim of this study was to analyze the associations of plasma aldosterone and plasma renin activity with the metabolic syndrome and each of its components. We analyzed data from a family based study in the Seychelles made up of 356 participants (160 men and 196 women) from 69 families of African descent. In multivariable models, plasma aldosterone was associated positively (P < 0.05) with blood pressure in older individuals (interaction with age, P < 0.05) and with waist circumference in men (interaction with sex, P < 0.05) and negatively with high-density lipoprotein cholesterol, in particular in individuals with elevated urinary potassium excretion (interaction with urinary potassium, P < 0.05); plasma renin activity was significantly associated with triglycerides and fasting blood glucose. Plasma aldosterone, but not plasma renin activity, was associated with the metabolic syndrome per se, independently of the association with its separate components. The observation that plasma renin activity was associated with some components of the metabolic syndrome, whereas plasma aldosterone was associated with other components of the metabolic syndrome, suggests different underlying mechanisms. These findings reinforce previous observations suggesting that aldosterone is associated with several cardiovascular risk factors and also suggest that aldosterone might contribute to the increased cardiovascular disease risk in individuals of African descent with the metabolic syndrome.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Higher plasma mineralocorticoid levels may be associated with insulin resistance.
“Higher plasma mineralocorticoid levels may be associated with IR (, ).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [165]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198 · see citing works
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214 · see citing works
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982 · see citing works
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941 · see citing works
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760 · see citing works
McNeill, A. M., Rosamond, W. D., Girman, C. J., Golden, S. H., Schmidt, M. I., East, H. E., Ballantyne, C. M., & HEISS, G. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.385 · Cited by 1,051 · see citing works
Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms
NICHOLS, W. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.10.009 · Cited by 1,002 · see citing works
Grundy, S. M., Hansen, B., Smith, S. C., Cleeman, J. I., Kahn, R. A., & Participants, F. C. (2004) · Circulation · doi:10.1161/01.cir.0000112379.88385.67 · Cited by 864 · see citing works
Obesity-Associated Hypertension
Rahmouni, K., Correia, M., Haynes, W. G., & Mark, A. L. (2004) · Hypertension · doi:10.1161/01.hyp.0000151325.83008.b4 · Cited by 780 · see citing works
Pitt, B., Wj, R., Zannad, F. M., Neaton, J. D., Martínez, F. A., Roniker, B., Bittman, R. M., Hurley, S., Kleiman, J. H., & Gatlin, M. R. (2003) · Cited by 708 · see citing works
Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study
Dekker, J. M., Girman, C. J., Rhodes, T., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2005) · Circulation · doi:10.1161/circulationaha.104.516948 · Cited by 633 · see citing works
Weight Loss and the Renin-Angiotensin-Aldosterone System
Engeli, S., Böhnke, J., Gorzelniak, K., Janke, J., Schling, P., Bäder, M., Luft, F. C., & Sharma, A. M. (2005) · Hypertension · doi:10.1161/01.hyp.0000154361.47683.d3 · Cited by 625 · see citing works
Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons
Vasan, R. S., Evans, J. C., Larson, M. G., Wilson, P. W. F., Meigs, J. B., Rifai, N., Benjamin, E. J., & Levy, D. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033263 · Cited by 573 · see citing works
Ford, E. S. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.12.022 · Cited by 501 · see citing works
Poulsen, K., & JØRGENSEN, J. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-5-816 · Cited by 448 · see citing works
Human adipocytes secrete mineralocorticoid-releasing factors
Ehrhart‐Bornstein, M., Lamounier‐Zepter, V., Schraven, A., Langenbach, J., Willenberg, H. S., Barthel, A., Hauner, H., McCann, S. M., Scherbaum, W. A., & Bornstein, S. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336140100 · Cited by 443 · see citing works
Pitt, B., White, H. D., Nicolau, J. C., Martínez, F. A., Gheorghiade, M., Aschermann, M., van Veldhuisen, D. J., Zannad, F. M., Krum, H., Mukherjee, R., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.038 · Cited by 387 · see citing works
The new biology of aldosterone
Connell, J., & Davies, E. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06017 · Cited by 353 · see citing works
Rossing, K., Schjoedt, K. J., Smidt, U., Boomsma, F., & Parving, H. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2106 · Cited by 297 · see citing works
High prevalence of primary aldosteronism in the Tayside hypertension clinic population
Lim, P. O., Dow, E., Brennan, G., Jung, R., & MacDonald, T. M. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001013 · Cited by 268 · see citing works
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus
Scheen, A. J. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70146-5 · Cited by 249 · see citing works
Visceral Obesity and Insulin Resistance Are Associated with Plasma Aldosterone Levels in Women
Goodfriend, T. L., Kelley, D. E., Goodpaster, B. H., & Winters, S. J. (1999) · Obesity Research · doi:10.1002/j.1550-8528.1999.tb00418.x · Cited by 235 · see citing works
Potentially high prevalence of primary aldosteronism in a primary-care population
Lim, P. O., Rodgers, P., Cardale, K., Watson, A., & MacDonald, T. M. (1999) · The Lancet · doi:10.1016/s0140-6736(05)74868-6 · Cited by 228 · see citing works
Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients
Flack, J. M., Oparil, S., Pratt, J. H., Roniker, B., Garthwaite, S. M., Kleiman, J. H., Yang, Y., Krause, S. L., Workman, D. L., & Saunders, E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00054-8 · Cited by 223 · see citing works
Epoxy-Keto Derivative of Linoleic Acid Stimulates Aldosterone Secretion
Goodfriend, T. L., Ball, D. L., Egan, B. M., Campbell, W. B., & Nithipatikom, K. (2004) · Hypertension · doi:10.1161/01.hyp.0000113294.06704.64 · Cited by 205 · see citing works
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus
Scheen, A. J. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70147-7 · Cited by 198 · see citing works
Gordon, R. D., Ziesak, M. D., Tunny, T. J., Stowasser, M., & Klemm, S. A. (1993) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1993.tb01687.x · Cited by 190 · see citing works
Blood pressure and hormone changes associated with weight reduction in the obese.
Sowers, J. R., Nyby, M. D., Stern, N., Beck, F. W., Baron, S. H., Catania, R. A., & Vlachis, N. (1982) · Hypertension · doi:10.1161/01.hyp.4.5.686 · Cited by 164 · see citing works
Goodfriend, T. L., Egan, B. M., & Kelley, D. E. (1998) · Endocrine Research · doi:10.3109/07435809809032689 · Cited by 144 · see citing works
Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.
Nussberger, J., D'amore, T. F., Porchet, M., Waeber, B., Brunner, D. B., Brunner, H. R., Kler, L., Brown, A., & Francis, R. J. (1987) · PubMed · Cited by 128 · see citing works
Laragh's lessons in pathophysiology and clinical pearls for treating hypertension
Laragh, J. H. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01301-7 · Cited by 127 · see citing works
Freel, E. M., & Connell, J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000132473.50966.14 · Cited by 121 · see citing works
Egan, B. M., Stepniakowski, K., & Goodfriend, T. L. (1994) · PubMed · doi:10.1016/0895-7061(94)p1710-h · Cited by 114 · see citing works
Role for aldosterone in blood pressure regulation of obese adolescents
Rocchini, A. P., Katch, V. L., Grekin, R. J., Moorehead, C., & Anderson, J. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90845-3 · Cited by 112 · see citing works
Arterial Pressure, Left Ventricular Mass, and Aldosterone in Essential Hypertension
El‐Gharbawy, A., NADIG, V., Kotchen, J. M., Grim, C. E., Sagar, K. B., Kaldunski, M. L., Hamet, P., Pausová, Z., Gaudet, D., Gossard, F., et al. (2001) · Hypertension · doi:10.1161/01.hyp.37.3.845 · Cited by 108 · see citing works
Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans
Goodfriend, T. L., Egan, B. M., & Kelley, D. E. (1999) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(99)80020-9 · Cited by 107 · see citing works
Repeated Administration of the Converting Enzyme Inhibitor Cilazapril to Normal Volunteers
Nussberger, J., D'amore, T. F., Porchet, M., Waeber, B., Brunner, D. B., Brunner, H. R., Kler, L., Brown, A., & Francis, R. J. (1987) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198701000-00007 · Cited by 103 · see citing works
Relationships Among Plasma Aldosterone, High-Density Lipoprotein Cholesterol, and Insulin in Humans
Goodfriend, T. L., Egan, B. M., Stepniakowski, K. T., & Ball, D. L. (1995) · Hypertension · doi:10.1161/01.hyp.25.1.30 · Cited by 98 · see citing works
Bovet, P., Shamlaye, C. F., Gabriel, A., Riesen, W., & Paccaud, F. M. (2006) · BMC Public Health · doi:10.1186/1471-2458-6-9 · Cited by 94 · see citing works
Egan, B. M., Stepniakowski, K. T., & Goodfriend, T. L. (1994) · American Journal of Hypertension · doi:10.1093/ajh/7.10.886 · Cited by 94 · see citing works
Is there a role for the ob gene product leptin in essential hypertension?
Suter, P. M., Locher, R., Hasler, E., & Vetter, W. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00162-9 · Cited by 93 · see citing works
Hyperaldosteronism and Hypertension
Grim, C. E., Cowley, A. W., Hamet, P., Gaudet, D., Kaldunski, M. L., Kotchen, J. M., Krishnaswami, S., Pausová, Z., Roman, R., Tremblay, J., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000154364.00763.d5 · Cited by 88 · see citing works
High Heritability of Ambulatory Blood Pressure in Families of East African Descent
Bochud, M., Bovet, P., Elston, R. C., Paccaud, F. M., Falconnet, C., Maillard, M. P., Shamlaye, C. F., & Burnier, M. (2005) · Hypertension · doi:10.1161/01.hyp.0000156538.59873.86 · Cited by 81 · see citing works
Pisciotta, L., Hamilton‐Craig, I. R., Tarugi, P., Bellocchio, A., Fasano, T., Alessandrini, P., Bon, G. B., Siepi, D., Mannarino, E., Cattin, L., et al. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.11.009 · Cited by 69 · see citing works
Bochud, M., Elston, R. C., Maillard, M. P., Bovet, P., Schild, L., Shamlaye, C. F., & Burnier, M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2005.00055.x · Cited by 59 · see citing works
Nussberger, J., Waeber, B., Brunner, H. R., Burris, J. F., & Vetter, W. (1984) · PubMed · Cited by 53 · see citing works
Egan, B. M., Papademetriou, V., Wofford, M. R., Calhoun, D. A., FERNANDES, J., RIEHLE, J., NESBITT, S., Michelson, E. L., & Julius, S. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.08.008 · Cited by 50 · see citing works
Role of the Metabolic Syndrome in Risk Assessment for Coronary Heart Disease
Kohli, P. (2006) · JAMA · doi:10.1001/jama.295.7.819 · Cited by 48 · see citing works
Haenni, A., Reneland, R., Lind, L., & Lithell, H. (2001) · Journal of Hypertension · doi:10.1097/00004872-200101000-00014 · Cited by 26 · see citing works
Metabolic cardiovascular risk factors and the renin-aldosterone system in essential hypertension.
Lind, L., Lithell, H., WIDE, L. E., & Ljunghall, S. (1992) · PubMed · Cited by 23 · see citing works
Insulin resistance in essential hypertension is related to plasma renin activity
Lind, L., Reneland, R., Andersson, P.-E., Haenni, A., & Lithell, H. (1998) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000642 · Cited by 18 · see citing works
Gaudio, G. V., Guasti, L., Schizzarotto, A., Simoni, C., Crespi, C., Cimpanelli, M., Klersy, C., Grandi, A. M., Riganti, G., & Venco, A. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000157442.95354.0d · Cited by 15 · see citing works
Laragh's lessons in pathophysiology and clinical pearls for treating hypertension
Laragh, J. H. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)01282-1 · Cited by 8 · see citing works
Validation and application of U.N. model life tables against Thailand data, 1973-1983.
Podhipak, A. (1987) · PubMed · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D’Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman‐Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 726 · see citing works
Huby, A.-C., Antonova, G., Groenendyk, J., Gomez-Sanchez, C. E., Bollag, W. B., Filosa, J. A., & de Chantemèle, E. J. B. (2015) · Circulation · doi:10.1161/circulationaha.115.018226 · Cited by 376 · see citing works
Sowers, J. R., Whaley-Connell, A., & Epstein, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00005 · Cited by 351 · see citing works
Aldosterone and end-organ damage
Brown, N. J. (2005) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000165889.60254.98 · Cited by 318 · see citing works
Enhanced Aldosterone Signaling in the Early Nephropathy of Rats with Metabolic Syndrome
Nagase, M., Yoshida, S., Shibata, S., Nagase, T., Gotoda, T., Ando, K., & Fujita, T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080944 · Cited by 247 · see citing works
Aldosterone and end-organ damage
Marney, A. M., & Brown, N. J. (2007) · Clinical Science · doi:10.1042/cs20070123 · Cited by 224 · see citing works
The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans
UNDERWOOD, P. C., & Adler, G. K. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0323-2 · Cited by 214 · see citing works
Body Mass Index Predicts Aldosterone Production in Normotensive Adults on a High-Salt Diet
Bentley–Lewis, R., Adler, G. K., Perlstein, T. S., Seely, E. W., Hopkins, P. N., Williams, G. H., & Garg, R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1088 · Cited by 213 · see citing works
Association of Adrenal Steroids With Hypertension and the Metabolic Syndrome in Blacks
Kidambi, S., Kotchen, J. M., Grim, C. E., Raff, H., Mao, J., Singh, R., & Kotchen, T. A. (2006) · Hypertension · doi:10.1161/01.hyp.0000253258.36141.c7 · Cited by 212 · see citing works
Ingelsson, E., Pencina, M. J., Tofler, G. H., Benjamin, E. J., Lanier, K. J., Jacques, P. F., Fox, C. S., Meigs, J. B., Levy, D. A., Larson, M. G., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.708537 · Cited by 195 · see citing works
The Role of the Renin-Angiotensin-Aldosterone System in Obesity-Related Renal Diseases
Rüster, C., & Wolf, G. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.12.002 · Cited by 189 · see citing works
Bankir, L., Bochud, M., Maillard, M. P., Bovet, P., Gabriel, A., & Burnier, M. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.105510 · Cited by 189 · see citing works
Thethi, T. K., Kamiyama, M., & Kobori, H. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0245-z · Cited by 178 · see citing works
The Renal Pathology of Obesity
Tsuboi, N., Okabayashi, Y., Shimizu, A., & Yokoo, T. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.01.007 · Cited by 153 · see citing works
The underlying mechanisms for development of hypertension in the metabolic syndrome
Yanai, H., Tomono, Y., Ito, K., Furutani, N., Yoshida, H., & Tada, N. (2008) · Nutrition Journal · doi:10.1186/1475-2891-7-10 · Cited by 171 · see citing works
Nagase, M., Matsui, H., Shibata, S., Gotoda, T., & Fujita, T. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.091058 · Cited by 157 · see citing works
Aldosterone and arterial hypertension
Tomaschitz, A., Pilz, S., Ritz, E., Obermayer-Pietsch, B. M., & Pieber, T. R. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.263 · Cited by 155 · see citing works
Colussi, G., Catena, C., Lapenna, R., Nadalini, E., Chiuch, A., & Sechi, L. A. (2007) · Diabetes Care · doi:10.2337/dc07-0525 · Cited by 155 · see citing works
Aldosterone: Role in the Cardiometabolic Syndrome and Resistant Hypertension
Whaley‐Connell, A. T., Johnson, M. S., & Sowers, J. R. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.12.004 · Cited by 152 · see citing works
Salt, aldosterone, and insulin resistance: impact on the cardiovascular system
Lastra, G., Dhuper, S., Johnson, M. S., & Sowers, J. R. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.123 · Cited by 151 · see citing works
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1105 · Cited by 140 · see citing works
Wuerzner, G., Pruijm, M., Maillard, M., Bovet, P., Renaud, C., Burnier, M., & Bochud, M. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.03.017 · Cited by 129 · see citing works
Mineralocorticoid Receptors, Salt-Sensitive Hypertension, and Metabolic Syndrome
Fujita, T. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.149062 · Cited by 130 · see citing works
Shibata, H., & Itoh, H. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2011.245 · Cited by 132 · see citing works
Lastra, G., Whaley-Connell, A., Manrique, C., Habibi, J., Gutweiler, A. A., Appesh, L., Hayden, M. R., Wei, Y., Ferrario, C., & Sowers, J. R. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00258.2007 · Cited by 119 · see citing works
Krug, A. W., Allenhöfer, L., Monticone, R. E., Spinetti, G., Gekle, M., Wang, M., & Lakatta, E. G. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.148783 · Cited by 115 · see citing works
Kelliny, C., William, J., Riesen, W., Paccaud, F. M., & Bovet, P. (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-27 · Cited by 113 · see citing works
Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets
Luther, J. M., Luo, P., Kreger, M. T., Brissova, M., Dai, C., Whitfield, T. T., Kim, H. S., Wasserman, D. H., Powers, A. C., & Brown, N. J. (2011) · Diabetologia · doi:10.1007/s00125-011-2158-9 · Cited by 109 · see citing works
Risk of new-onset diabetes mellitus in primary aldosteronism
Wu, V., Chueh, S., Chen, L., Chang, C., Hu, Y., Lin, Y., Wu, K., & Yang, W. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001361 · Cited by 106 · see citing works
Aldosterone and Metabolic Syndrome
Krug, A. W., & Ehrhart‐Bornstein, M. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.109439 · Cited by 103 · see citing works
Adipocytes, aldosterone and obesity-related hypertension
Cat, A. N. D., Friederich‐Persson, M., White, A. D., & Touyz, R. M. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0025 · Cited by 96 · see citing works
The role of obesity in the pathogenesis of hypertension
Bogaert, Y. E., & Linas, S. L. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph1022 · Cited by 95 · see citing works
A possible association between primary aldosteronism and a lower β-cell function
Mosso, L. M., Carvajal, C. A., Maiz, A., Ortiz, E. H., Castillo, C. R., Artigas, R. A., & Fardella, C. E. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282861fa4 · Cited by 94 · see citing works
The Role of Aldosterone in the Metabolic Syndrome
Briet, M. B., & Schiffrin, E. L. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0182-2 · Cited by 93 · see citing works
Aldosterone excess impairs first phase insulin secretion in primary aldosteronism
Fischer, E., Adolf, C., Pallauf, A., Then, C., Bidlingmaier, M., Beuschlein, F., Seissler, J., & Reincke, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3934 · Cited by 88 · see citing works
Circulating Aldosterone and Natriuretic Peptides in the General Community
Buglioni, A., Cannone, V., Cataliotti, A., Sangaralingham, S. J., Heublein, D. M., Scott, C. G., Bailey, K. R., Rodeheffer, R. J., Dessı̀-Fulgheri, P., Sarzani, R., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03936 · Cited by 85 · see citing works
Mineralocorticoid receptors in the metabolic syndrome
Zennaro, M., Caprio, M., & Fève, B. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.05.006 · Cited by 79 · see citing works
The regulation of aldosterone secretion by leptin
Faulkner, J., Bruder-Nascimento, T. B., & de Chantemèle, E. J. B. (2017) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000384 · Cited by 85 · see citing works
Adipokines and Cardiometabolic Profile in Primary Hyperaldosteronism
Iacobellis, G., Petramala, L., Cotesta, D., Pergolini, M., Zinnamosca, L., Cianci, R., Toma, G. D., Sciomer, S., & Letizia, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2204 · Cited by 80 · see citing works
Aldosterone in salt-sensitive hypertension and metabolic syndrome
Fujita, T. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0343-1 · Cited by 80 · see citing works
Aldosterone and glomerular podocyte injury
Nagase, M., & Fujita, T. (2008) · Clinical and Experimental Nephrology · doi:10.1007/s10157-008-0034-9 · Cited by 78 · see citing works
The Role of Aldosteronism in Causing Obesity-Related Cardiovascular Risk
Calhoun, D. A., & Sharma, K. (2010) · Cardiology Clinics · doi:10.1016/j.ccl.2010.04.001 · Cited by 74 · see citing works
Marzolla, V., Feraco, A., Gorini, S., Mammi, C., Marrese, C., Mularoni, V., Boitani, C., Lombès, M., Kolkhof, P., Ciriolo, M. R., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000164r · Cited by 72 · see citing works
Aldosterone and Cardiovascular Disease
Gaddam, K. K., Pimenta, E., Husain, S., & Calhoun, D. A. (2009) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2008.10.002 · Cited by 69 · see citing works
The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism
Šomlóová, Z., Widimský, J., Rosa, J., Wichterle, D., Štrauch, B., Petrák, O., Zelinka, T., Vlková, J., Mašek, M., Dvořáková, J., et al. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.65 · Cited by 68 · see citing works
Musani, S. K., Vasan, R. S., Bidulescu, A., Liu, J., Xanthakis, V., Sims, M., Gawalapu, R. K., Samdarshi, T. E., Steffes, M. W., Taylor, H. A., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2562 · Cited by 66 · see citing works
Mineralocorticoid receptor activation in obesity hypertension
Nagase, M., & Fujita, T. (2009) · Hypertension Research · doi:10.1038/hr.2009.86 · Cited by 64 · see citing works
Savarese, G., Lindberg, F., Filippatos, G. S., Butler, J., & Anker, S. D. (2023) · Diabetologia · doi:10.1007/s00125-023-06031-1 · Cited by 64 · see citing works
The role of radiologic studies in the evaluation and management of primary hyperaldosteronism
White, M. L., Gauger, P. G., Doherty, G. M., Cho, K. J., Thompson, N. W., Hammer, G. D., & Miller, B. S. (2008) · Surgery · doi:10.1016/j.surg.2008.07.025 · Cited by 62 · see citing works
Thuzar, M., Law, W. P., Dimeski, G., Stowasser, M., & Ho, K. K. Y. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13539 · Cited by 61 · see citing works
Abnormal Aldosterone Physiology and Cardiometabolic Risk Factors
Vaidya, A., UNDERWOOD, P. C., Hopkins, P. N., Jeunemaı̂tre, X., Ferri, C., Williams, G. H., & Adler, G. K. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00662 · Cited by 58 · see citing works
New Pandemic: Obesity and Associated Nephropathy
Sharma, I., Liao, Y., Zheng, X., & Kanwar, Y. S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.673556 · Cited by 57 · see citing works
Association of plasma aldosterone with the metabolic syndrome in two German populations
Hannemann, A., Meisinger, C., Bidlingmaier, M., Döring, A., Thorand, B., Heier, M., Belcredi, P., Ladwig, K., Wallaschofski, H., Friedrich, N., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1074 · Cited by 57 · see citing works
Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
Stiefel, P., Vallejo‐Vaz, A. J., Morillo, J. S. G., & Villar, J. (2011) · International Journal of Hypertension · doi:10.4061/2011/685238 · Cited by 55 · see citing works
Orena, S., Maurer, T. S., She, L., Eudy, R. J., Bernardo, V., Dash, D., Loria, P. M., Banker, M. E., Tugnait, M., Okerberg, C. V., et al. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00115 · Cited by 54 · see citing works
The NLPR3 inflammasome and obesity‐related kidney disease
Ke, B., Shen, W., Fang, X., & Wu, Q. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13333 · Cited by 54 · see citing works
Impact of Adrenal Steroids on Regulation of Adipose Tissue
Infante, M., Armani, A., Mammi, C., Fabbri, A., & Caprio, M. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160037 · Cited by 52 · see citing works
Insulin resistance and salt-sensitive hypertension in metabolic syndrome
Fujita, T. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm409 · Cited by 51 · see citing works
Aldosterone and Cardiovascular Disease
Calhoun, D. A. (2006) · Circulation · doi:10.1161/circulationaha.106.668715 · Cited by 51 · see citing works
Raimundo, M. R., & Lopes, J. A. (2011) · Cardiology Research and Practice · doi:10.4061/2011/747861 · Cited by 50 · see citing works
Li, W., Chen, X., Riley, A. M., Hiett, S. C., Temm, C. J., Beli, E., Long, X., Chakraborty, S., Alloosh, M., White, F. A., et al. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0643-0 · Cited by 50 · see citing works
Bomback, A. S., & Klemmer, P. J. (2009) · American Journal of Nephrology · doi:10.1159/000209744 · Cited by 48 · see citing works
Aldosterone: A cardiovascular risk factor?
Funder, J. W., & Reincke, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.08.005 · Cited by 47 · see citing works
Shah, V. N., Cheema, B. S., Sharma, R., Khullar, M., Kohli, H. S., Ahluwalia, T. S., Mohan, V., & Bhansali, A. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1460-2 · Cited by 47 · see citing works
The Association of Aldosterone With Obesity-Related Hypertension and the Metabolic Syndrome
Vogt, B., Bochud, M., & Burnier, M. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.07.009 · Cited by 47 · see citing works
Links between aldosterone excess and metabolic complications: A comprehensive review
Bothou, C., Beuschlein, F., & Spyroglou, A. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.02.003 · Cited by 46 · see citing works
Essick, E. E., & Sam, F. (2011) · International Journal of Hypertension · doi:10.4061/2011/346985 · Cited by 45 · see citing works
Barceló, A., Piérola, J., Esquinas, C., de la Peña, M., Arqué, M., Alonso‐Fernández, A., Bauçà, J. M., Robles, J., Martín, B. B., & Barbé, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084362 · Cited by 44 · see citing works
Obesity in kidney disease: A heavyweight opponent
Felizardo, R. J. F. (2014) · World Journal of Nephrology · doi:10.5527/wjn.v3.i3.50 · Cited by 44 · see citing works
Jia, G., Lockette, W. E., & Sowers, J. R. (2021) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00280.2020 · Cited by 45 · see citing works
Nagase, M. (2010) · Clinical and Experimental Nephrology · doi:10.1007/s10157-010-0298-8 · Cited by 43 · see citing works
Aldosterone, From (Patho)Physiology to Treatment in Cardiovascular and Renal Damage
Waanders, F., de Vries, L. V., van Goor, H., Hillebrands, J., Laverman, G. D., Bakker, S. J. L., & Navis, G. J. (2011) · Current Vascular Pharmacology · doi:10.2174/157016111796642689 · Cited by 41 · see citing works
The Mineralocorticoid Receptor in Salt-Sensitive Hypertension and Renal Injury
Ayuzawa, N., & Fujita, T. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020071041 · Cited by 41 · see citing works
Sueta, D., Yamamoto, E., & Tsujita, K. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-1023-y · Cited by 39 · see citing works
Davel, A. P., Jaffe, I. Z., Tostes, R. C., Jaisser, F., & de Chantemèle, E. J. B. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00073.2018 · Cited by 39 · see citing works
The mineralocorticoid receptor—an emerging player in metabolic syndrome?
Thuzar, M., & Stowasser, M. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-020-00467-3 · Cited by 38 · see citing works
Goyal, B. R., Solanki, N. D., Goyal, R. K., & Mehta, A. A. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181be75cc · Cited by 37 · see citing works
Risk factor assessment for new onset diabetes: literature review
Bakris, G. L., Stockert, J., Molitch, M. E., Zhou, Q., Champion, A., Bacher, P. H., Sowers, J. R., & on behalf of the STAR Investigators (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00925.x · Cited by 36 · see citing works
Shibata, S., & Fujita, T. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.018 · Cited by 36 · see citing works
Asrih, M., Mach, F., Nencioni, A., Dallegri, F., Quercioli, A., & Montecucco, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/367245 · Cited by 35 · see citing works
Kawarazaki, H., Ando, K., Shibata, S., Muraoka, K., Fujita, M., Kawarasaki, C., & Fujita, T. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283576904 · Cited by 35 · see citing works
Huan, Y., DeLoach, S. S., Keith, S. W., Goodfriend, T. L., & Falkner, B. E. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.09.005 · Cited by 35 · see citing works
Gorini, S., Marzolla, V., Mammi, C., Armani, A., & Caprio, M. (2018) · Biomolecules · doi:10.3390/biom8030096 · Cited by 35 · see citing works
Bariatric surgery and hypertension
Bueter, M., Ahmed, A. R., Ashrafian, H., & le Roux, C. W. (2009) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.03.218 · Cited by 34 · see citing works
Mulè, G., Nardi, E., Cusimano, P., Cottone, S., Seddio, G., Geraci, C., Palermo, A., Andronico, G., & Cerasola, G. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.225 · Cited by 33 · see citing works
Nizar, J. M., Shepard, B. D., Vo, V., & Bhalla, V. (2018) · JCI Insight · doi:10.1172/jci.insight.95107 · Cited by 33 · see citing works
The Renal Pathology of Obesity: Structure-Function Correlations.
Tsuboi, N., & Okabayashi, Y. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.06.002 · Cited by 28 · see citing works
Hannich, M. J., Wallaschofski, H., Nauck, M. A., Reincke, M., Adolf, C., Völzke, H., Rettig, R., & Hannemann, A. (2018) · International Journal of Endocrinology · doi:10.1155/2018/4128174 · Cited by 31 · see citing works
Katsuragawa, S., Goto, A., Shinoda, S., Inoue, K., Nakai, K., Saito, J., Nishikawa, T., & Tsurutani, Y. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21096 · Cited by 31 · see citing works
Hypertension, Insulin Resistance, and Aldosterone: Sex‐Specific Relationships
Kidambi, S., Kotchen, J. M., Krishnaswami, S., Grim, C. E., & Kotchen, T. A. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2009.00084.x · Cited by 29 · see citing works
Russo, P., Lauria, F., Loguercio, M., Barba, G., Arnout, J., Cappuccio, F. P., Delorgeril, M., Donati, M. B., Iacoviello, L., & Krogh, V. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.07.012 · Cited by 29 · see citing works
Goupil, R., Desbiens, L., Merabtine, A., Agharazii, M., Madore, F., Vaidya, A., Leung, A. A. C., Kline, G. A., Shaw, J. L. V., Ramsay, T., et al. (2025) · Circulation · doi:10.1161/circulationaha.124.073507 · Cited by 28 · see citing works
Scott, L., Woodiwiss, A. J., Maseko, M. J., Veliotes, D. G. A., Majane, O. H. I., Paiker, J. E., Sareli, P., & Norton, G. R. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.49 · Cited by 28 · see citing works
Bellili-Muñoz, N., Foucan, L., Fumeron, F., Mohammedi, K., Travert, F., Roussel, R., Balkau, B., Tichet, J., Marre, M., & ; the D.E.S.I.R. Study Group (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.44 · Cited by 27 · see citing works
Sato, A. (2015) · Hypertension Research · doi:10.1038/hr.2015.19 · Cited by 26 · see citing works
The metabolic syndrome in primary aldosteronism
Fallo, F., Federspil, G., Veglio, F., & Mulatero, P. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0009-y · Cited by 26 · see citing works
Byrd, J. B., & Brook, R. D. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2013.42 · Cited by 25 · see citing works
Sex Differences in Leptin Control of Cardiovascular Function in Health and Metabolic Diseases
de Chantemèle, E. J. B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_6 · Cited by 25 · see citing works
Berends, A. M. A., Buitenwerf, E., Gruppen, E. G., Sluiter, W. J., Bakker, S. J. L., Connelly, M. A., Kerstens, M. N., & Dullaart, R. P. F. (2018) · Clinical Endocrinology · doi:10.1111/cen.13891 · Cited by 24 · see citing works
Kesireddy, V., Tan, Y., Kline, D., Brock, G. N., Odei, J. B., Kluwe, B., Effoe, V. S., Echouffo-Tcheugui, J. B., Kalyani, R. R., Sims, M., et al. (2019) · Nutrients · doi:10.3390/nu11050955 · Cited by 23 · see citing works
- Authors
- Bochud, M., Nussberger, J., Bovet, P., Maillard, M. R., Elston, R. C., Paccaud, F., Shamlaye, C., & Burnier, M.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- From the Department of Epidemiology and Biostatistics (M. Bochud, R.C.E.), Case Western Reserve University, Cleveland, Ohio; Institut Universitaire de Médecine Sociale et Préventive (M. Bochud, P.B., F.P.), Lausanne, Switzerland; Département de Médecine et Service de Néphrologie (J.N., M.R.M., M. Burnier), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; and the Ministry of Health (P.B., C.S.), Victoria, Seychelles.
- Venue
- Hypertension
- Published
- 2006-08
- Volume
- 48
- Issue
- 2
- Pages
- 239-245
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2124037655
- Cited by
- 226
- References
- 55
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 4 · 2023: 6 · 2022: 12 · 2021: 12 · 2020: 5 · 2019: 5 · 2018: 14 · 2017: 13 · 2016: 3 · 2015: 10 · 2014: 13 · 2013: 14 · 2012: 14
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- National Institute of General Medical Sciences (GM-28356)
- National Center for Research Resources (RR-03655, P41RR003655)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- plasma aldosterone, plasma renin activity, metabolic syndrome, blood pressure, waist circumference, HDL cholesterol, potassium excretion, triglycerides, fasting blood glucose, cardiovascular risk, African ancestry
- MeSH terms
- Africa, Eastern, Aldosterone, Blood Pressure, Female, Humans, Male, Middle Aged, Regression Analysis, Renin, Risk Factors, Seychelles, Models, Statistical, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
